Clinical Trial Update: ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bevacizumab, erlotinib, and capecitabine in locally advanced or metastatic pancreatic cancer has completed, with results posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Tarceva (erlotinib)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-08-07